Lorbriqua 100mg Tablet
Marketer
Pfizer Ltd
Salt Composition
Lorlatinib (100mg)
Overview Lorbriqua 100mg Tablet
Adults with unresectable, advanced, or recurrent non-small cell lung cancer (NSCLC) may be treated with Lorbriqua 100mg tablets. This medication targets anaplastic lymphoma kinase (ALK), an enzyme, effectively in patients exhibiting ALK alterations. A Tata 1mg-managed Patient Support/Assistance Program is available in India. For further information, consult your physician or call (1800-102-1618).
Primary Ingredients of Lorbriqua 100mg Tablet
No text provided. Please provide the text you wish to be rephrased.
Uses of Lorbriqua 100mg Tablet
Managing Non-small Cell Lung Carcinoma
Major Benefits of Lorbriqua 100mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. The tablet should be swallowed whole; avoid chewing, crushing, or fracturing it. Lorbriqua 100mg Tablets can be ingested with or without food, though consistent timing is recommended.
Common Side effects of Lorbriqua 100mg Tablet:
- Fatigue
- Diarrhea
- Edema (swelling)
- High blood pressure
- Cough
- Joint pain
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Weight gain
- Breathlessness
- Mood changes
- Hypercholesterolemia (high cholesterol)
- Increased triglyceride level in blood
How to use Lorbriqua 100mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lorbriqua 100mg Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
How Lorbriqua 100mg Tablet works:
Oncaspar 100mg tablets are a cancer treatment. Their mechanism involves inhibiting the activity of a faulty protein responsible for triggering cancerous cell proliferation. This action helps to curb or decelerate the growth of malignant cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lorbriqua 100mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Lorbriqua 100mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Use of Lorbriqua 100mg tablets necessitates careful consideration while breastfeeding. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Lorbriqua 100mg Tablet is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with severe kidney disease should use Lorbriqua 100mg Tablets cautiously, potentially requiring a modified dosage. Mild to moderate kidney impairment, however, doesn't necessitate dosage changes. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Lorbriqua 100mg tablets are considered safe for use by individuals with liver disease; no alteration to the prescribed dosage is necessary. Nevertheless, dosing guidelines for patients experiencing moderate to severe hepatic dysfunction haven't been determined.
What if you forget to take Lorbriqua 100mg Tablet :
NA
Facts to Know About Lorbriqua 100mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenylpropanoid compounds |
| Developing Habits | No. |
| Type of Treatment | Cancer Medications |
| Behavioral Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently